Ardsley Advisory Partners’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,500	Closed	-$257K	–	141
2020 Q2	$257K	Buy	+7,500	New	+$257K	0.05%	100